Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Profiling the Inflammatory Cascade of COVID-19

  • Read more about Profiling the Inflammatory Cascade of COVID-19

Transcutaneous Vagus Nerve Stimulation (tVNS) for Improved Recovery After Exertion.

  • Read more about Transcutaneous Vagus Nerve Stimulation (tVNS) for Improved Recovery After Exertion.

M-I/E for Preventing VAP in Post-neurosurgical Patients

  • Read more about M-I/E for Preventing VAP in Post-neurosurgical Patients

Modified Thoracoabdominal Nerve Plane Block In Laparoscopic Sleeve Gastrectomy

  • Read more about Modified Thoracoabdominal Nerve Plane Block In Laparoscopic Sleeve Gastrectomy

Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)

  • Read more about Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)

COVID-Related Tinnitus Timeline

  • Read more about COVID-Related Tinnitus Timeline

Steroid Treatment for Severe Acute Respiratory Infection (STAR) Trial

  • Read more about Steroid Treatment for Severe Acute Respiratory Infection (STAR) Trial

Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients

  • Read more about Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients

Subcutaneous Sarilumab vs Placebo in Hospitalized Patients With Respiratory Distress Caused by COVID 19

  • Read more about Subcutaneous Sarilumab vs Placebo in Hospitalized Patients With Respiratory Distress Caused by COVID 19

IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition

  • Read more about IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 32
  • Page 33
  • Page 34
  • Page 35
  • Current page 36
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA